Imunon, Inc. — Director's Dealing 2011

May 31, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2011-05-26

Reporting Person: Hooper Robert W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-05-26	Celsion Corporation Common Stock	P	25907	$2.77	Acquired	33907	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-05-26	Warrants to purchase Common Stock	$2.77	P	25907	Acquired	2017-05-26	Celsion Corporation Common Stock (25907)	Direct

Footnotes

F1: The securities were purchased in a private placement transaction dated May 26, 2011 between Celsion Corporation and institutional investors as well as certain officers and directors of Celsion Corporation.

F2: Represents the closing consolidated bid price as reported on NASDAQ on the date of the transaction.

F3: Each warrant to purchase one share of common stock was purchased for $0.125 per unit, which represents the value allocated to the warrant in accordance with the NASDAQ Stock Market Rules.